Meloxicam Completed Phase 2 Trials for Dysmenorrhea Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02183025Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea